{"id":4115,"date":"2025-03-16T21:20:05","date_gmt":"2025-03-16T20:20:05","guid":{"rendered":"https:\/\/www.biocontact.info\/en\/?page_id=4115"},"modified":"2026-02-20T18:25:20","modified_gmt":"2026-02-20T17:25:20","slug":"contact2025-program","status":"publish","type":"page","link":"https:\/\/www.biocontact.info\/en\/contact2025-program\/","title":{"rendered":"CONTACT2025 Program"},"content":{"rendered":"
\n \n \n\t\n\n\n\n
\n

In addition to numerous exhibition stands, CONTACT2025 offers visitors the opportunity to find out about the various aspects of starting a career, career opportunities and prospects in the life sciences industry with a varied programme of presentations. The exhibiting companies will present their companies in quarter-hour or half-hour presentations. The events will be held in English!<\/p>\n<\/div><\/div>\n<\/section>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Ground Floor\/
Stage 1<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

K1\/ K2<\/h2>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

10:00 -
10:15<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Welcome <\/span>| Prof. D. Odom<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

\u00a0<\/h2>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

10:15 - 10:40<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

BASF <\/span>| L. Grabowski<\/h2>\n

Process development for biocatalysis at scale<\/p>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Catalant <\/span>| A. Ihrig<\/h2>\n

\u00a0Karrierestart in der Pharmabranche - CDMOs<\/p>\n

German<\/h6>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

10:40 - 11:05<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

ZS Associate <\/span>| D. Samantaray, C. Vorabbi, A. Hirth\u00a0<\/h2>\n

ZS Associate - Journey from Academia to Life-Science Consulting<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Lamm HR <\/span>| K. Lamm<\/h2>\n

Wieso bekomme ich nur Standardabsagen? <\/p>\n

German<\/h6>\n<\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n

AIRNA <\/span>| Dr. P. Vogel<\/h2>\n

AIRNA\u2019s RNA editing therapeutics offer new exciting opportunities<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

11:05 - 11:30<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Arcondis <\/span>| Dr. T. Ziegler, Dr. A. M. Ouayoue<\/h2>\n

Become a Life Science Hero with Arcondis<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Biomedx <\/span>| T. R\u00fcckle<\/h2>\n

The BioMed X model:combining the best of academia and industry for drug discovery<\/p>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

11:30 - 11:55<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Boehringer Ingelheim <\/span>| Dr. M. Latuske<\/h2>\n

Exploring Pharma Research: Insights into Boehringer Ingelheim<\/p>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Singleron <\/span>| B. Altaha<\/h2>\n

Latest updates for Single cell technologies<\/p>\n<\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n

Patent attorney ULLRICH & NAUMANN <\/span>| Dr. M. Heimes<\/h2>\n

Patent attorney - working at the interface of scientific innovation and commercialization through the protection of intellectual propery<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

11:55 -
12:30<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Lunch break<\/h2>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

12:30 - 12:55<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Sanofi <\/span>| K. K\u00f6hler<\/h2>\n

Sanofi - Dein Einstieg in einem globalen Gesundheitsunternehmen<\/p>\n

GERMAN<\/h6>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Infectopharma <\/span>| Dr. C. Knauer, V. Brabez<\/h2>\n

\u00a0Ihre Karrierem\u00f6glichkeiten bei InfectoPharm<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

12:55 - 13:20<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

HOX <\/span>| Dr. M. Gruber, Dr. M. Merli<\/h2>\n

How to Become a Project Manager in the Industry?<\/p>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

CordenPharma <\/span>| K. Kelsch<\/h2>\n

Ihre Karriere bei CordenPharma<\/p>\n

German<\/h6>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

13:20 - 13:45<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

DKFZ <\/span>| Dr. B. Janssens<\/h2>\n

Career Paths in the Life Sciences<\/p>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Mementis <\/span>| A. Vidina<\/h2>\n

of Miniaturization in Advancing Microfluidics for Life Sciences<\/p>\n<\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n

PEPperPRINT <\/span>| S. Schott<\/h2>\n

Business development in a peptide microarray company \u2013 Between science and business<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

13:45 -
14:10<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Coffee break, networking<\/h2>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

14:10 -
15:30<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Panel discussion<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Panel discussion<\/h2>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

15:30 - 15:45<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Coffee break, networking<\/h2>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

15:45 - 16:10<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Scitaris <\/span>| Dr. M. Pekmezovic, Dr. M. Klimontova<\/h2>\n

Biopharma Strategy Consulting-Transition from Academia to Industry<\/p>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Biomovis <\/span>| Dr. M. Stieler<\/h2>\n

Working at an Early-Stage Startup \u2013 Opportunities and Challenges<\/p>\n<\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n

Sciomics <\/span>| M. Eutebach<\/h2>\n

Sciomics. Daily innovation - a typical day in a startup<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

16:10 - 16:35<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Metasystems <\/span>| Dr. C. Schunck, L. Moncada<\/h2>\n

MetaSystems \u2013 a Hidden Champion in the Region<\/p>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Spektrum der Wissenschaft <\/span>| Dr. F. Schubert<\/h2>\n

Als WissenschaftsredakteurIn arbeiten<\/p>\n

German<\/h6>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

16:35 - 17:00<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Procter & Gamble <\/span>| J. Hernandez<\/h2>\n

P&G - A great place to work<\/p>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Kriminaltechnisches Institut <\/span>| Dr. P. Zimmermann<\/h2>\n

\u00a0Naturwissenschaften in Ermittlungs- und Strafverfahren<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>

\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

17:00 - 17:25<\/h2>\n<\/div>\n<\/div>\n<\/div>
\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

Rentschler <\/span>| J. M. Lerch<\/h2>\n

Write Your Story at Rentschler Biopharma<\/p>\n

\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n
\n

aGAP2 <\/span>| S. Ganskih<\/h2>\n

\u00a0Abwechslung gef\u00e4llig? Projektarbeit bei agap2<\/p>\n

German<\/h6>\n<\/div>\n<\/div>\n<\/div><\/div>
\n\n\n
\n
\n \t <\/div>\n<\/div>\n\n<\/div><\/div>\n<\/section>
\n \n \n\t\n\n\n\n
\n

<\/h2>\n

Panel discussion<\/h2>\n

<\/h2>\n

This year, we are offering a stimulating panel discussion<\/strong> at CONTACT2025. This will take place from 14:10 - 15:30<\/strong> on Stage I<\/strong>. The discussion language will be English<\/strong> and the topic will be:<\/p>\n

<\/h2>\n

Navigating a difficult job market <\/strong>
How to Stand Out and Find Future-Proof Careers<\/strong><\/p>\n

<\/h2>\n

In today\u2019s competitive job market, standing out is more challenging than ever. As industries evolve and new technologies emerge, some roles are growing rapidly while others are fading away. But how can you identify which career fields are expected to grow in the future and ensure your skills remain relevant?

Join us for a dynamic panel discussion where industry experts will explore the kinds of positions expected to expand in the coming years and what you can do to rise above the competition. Discover strategies to adapt to a changing job landscape and learn how to highlight your unique strengths. Whether you\u2019re about to graduate or just starting to map out your career path, this event offers the insights you need to navigate the job market. Don\u2019t miss this opportunity to gain valuable advice and start shaping your future today.<\/p>\n

<\/h2>\n<\/div><\/div>\n<\/section>
\n \n \n\t\n\n\n\n

\nThe following companies will take part in the panel discussion:\n<\/h2>
\n \n \n\t\n\n\n\n
\n
\n\t
\n\t\t
<\/div>\n\t<\/div><\/figure>\n\n<\/div>
\n
\n\t
\n\t\t
<\/div>\n\t<\/div><\/figure>\n\n<\/div>
\n
\n\t
\n\t\t
<\/div>\n\t<\/div><\/figure>\n\n<\/div>
\n
\n\t
\n\t\t
<\/div>\n\t<\/div><\/figure>\n\n<\/div>
\n
\n\t
\n\t\t
<\/div>\n\t<\/div><\/figure>\n\n<\/div>
\n
\n\t
\n\t\t
<\/div>\n\t<\/div><\/figure>\n\n<\/div>\n<\/div>
\n\n\n